Gastric ESD may be useful as accurate staging and decision of future therapeutic strategy

Abstract

Background and study aims We sometimes perform gastric endoscopic submucosal dissection (ESD) for total pathologic diagnosis when preoperative diagnosis is difficult. In the present study we analyzed the treatment outcomes and adverse events of diagnostic ESD for early gastric cancer (EGC).

Patients and methods We conducted a retrospective analysis of 18 consecutive cases of EGC in 18 patients with a suspected out-of-indication diagnosis who underwent diagnostic ESD, between June 2010 and November 2014. The following parameters were examined: the average length of the longer axis of the lesion; the procedure time; the rates of en bloc resection (ER), complete en bloc resection (CER), and curative resection (CR) as treatment outcomes; and the rates of perforation, delayed bleeding, aspiration pneumonia, disease-related death, and emergency surgery as adverse events.

Results The treatment outcomes were as follows: average length of the longer axis of the lesion, 27.4 ± 10.0 mm; procedure time, 87.0 ± 43.1 minutes; ER rate, 18/18 (100.0 %); CER rate, 13/18 (72.2 %); CR rate, 4/18 (22.2 %). CR rate was achieved 37.5 % for the lesions which preoperative diagnosis was more than 30 mm (> 30 mm) in diameter differentiated type with mucosal layer/submucosal layer 1 invasion and ulceration positive. The adverse events (AEs) were perforation in 1 of 18 (5.5 %) patients and delayed bleeding in 1 of 18 (5.5 %). There were no other AEs.

Conclusions Diagnostic ESD may be acceptable for future therapeutic strategy when we unconfirmed the pre ESD diagnosis because of lower rate of adverse events and high rate of ER.

• References

• 1 Neuhaus H. ESD around the world: Europe. Gastrointest Endosc Clin N Am 2014; 24: 295-311
• 2 Kim MY, Cho JH, Jain P. et al. ESD around the world: Asia. Gastrointest Endosc Clin N Am 2014; 24: 283-293
• 3 Japanese Gastric Cancer Association: Gastric cancer treatment guideline. 4th ed. Tokyo: Kanahara; 2014: 20-23 (in Japanese)
• 4 Toyonaga T, Man-i M, East JE. et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc 2013; 27: 1000-1008
• 5 Gotoda T, Oda I, Tamakawa K. et al. Prospective clinical trial of magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer (with videos). Gastrointest Endosc 2009; 69: 10-15
• 6 Lee WS, Cho JW, Kim YD. et al. Technical issues and new devices of ESD of early gastric cancer. World J Gastroenterol 2011; 17: 3585-3590
• 7 Gotoda T, Yanagisawa A, Sasako M. et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000; 3: 219-225
• 8 Abe S, Oda I, Shimazu T. et al. Depth-predicting score for differentiated early gastric cancer. Gastric Cancer 2011; 14: 35-40
• 9 Yoshinaga S, Oda I, Nonaka S. et al. Endoscopic ultrasound using ultrasound probes for the diagnosis of early esophageal and gastric cancers. World J Gastrointest Endosc 2012; 4: 218-226
• 10 Sato S, Chonan A, Mishima T. et al. Diagnosis of the Depth of Cancer Invasion for Early Gastric Cancer. Stomach and Intestine 2014; 49: 65-75 (in Japanese)
• 11 Maruyama Y, Shimamura T, Koda K. et al. Diagnosis of the Depth of Early Gastric Cancer by Conventional and Dying Endoscopy from the View Point of the Size and Macroscopic Type. Stomach and Intestine 2014; 49: 35-46 (in Japanese)
• 12 Nagahama T, Yao K, Imamura K. et al. Diagnostic performance of conventional endoscopy in the identification of submucosal invasion by early gastric cancer: the “non-extension sign” as a simple diagnostic marker. Gastric Cancer Epub 2016; DOI: [Epub ahead of print]
• 13 Yamamoto H, Kawata H, Sunada K. et al. Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy 2003; 35: 690-694
• 14 Fujisjiro M, Yahagi N, Kashimura K. et al. Comparison of various submucosal injection solutions for maintaining mucosal elevation during EMR. Endoscopy 2004; 36: 579-583
• 15 Yamaguchi N, Isomoto H, Fukuda E. et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer by indication criteria. Digestion 2009; 80: 173-181
• 16 Suzuki H, Oda I, Nonaka S. et al. Is endoscopic submucosal dissection an effective treatment for operable patients with clinical submucosal invasive early gastric cancer?. Endoscopy 2013; 45: 93-97
• 17 Sano T, Okuyama Y, Kobori O. et al. Early gastric cancer. Endoscopic diagnosis of depth of invasion. Dig Dis Sci 1990; 35: 1340-1344
• 18 Ono H, Yoshida M. Endoscopic diagnosis of the depth of cancer invasion for gastric cancer. Stomach and Intestine 2001; 36: 334-340 (In Japanese with English abstract)
• 19 Inoue H, Ikeda H, Hosoya T. et al. Endoscopic mucosal resection, endoscopic submucosal dissection, and beyond: full-layer resection for gastric cancer with nonexposure technique (CLEAN-NET). Surg Oncol Clin N Am 2012; 21: 129-140
• 20 Goto O, Takeuchi H, Kawakubo H. et al. Feasibility of non-exposed endoscopic wall-inversion surgery with sentinel node basin dissection as a new surgical method for early gastric cancer: a porcine survival study. Gastric Cancer 2015; 18: 440-445
• 21 Yanai H, Matsumoto Y, Harada T. et al. Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: a pilot study. Gastrointest Endosc 1997; 46: 212-216
• 22 Yamaguchi N, Isomoto H, Fukuda E. et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer by indication criteria. Digestion 2009; 80: 173-181
• 23 Kakushima N, Hagiwara T, Tanaka M. et al. Endoscopic submucosal dissection for early gastric cancer in cases preoperatively contraindicated for endoscopic treatment. United European Gastroenterol J 2013; 1: 453-460